Doug Hampton Hunt Scanlon has named Prestige Scientific to its exclusive 2023 Top 40 Life Sciences Search Firms List MILFORD, Mass., June 5, 2023 /PRNewswire/ — “Prestige Scientific is honored to be recognized as one of the Top 40 Life Sciences Search Firms. We are grateful for our incredible team that we’ve built over 22+ years in business. … Read more
Subjects in Bunionectomy Study Dosed Data Presented at American Society for Pharmacology and Experimental Therapeutics Shows Similar Ropivacaine Pharmacokinetic Curves From CPL-01 Across Multiple Surgeries; Minimal Variability as Compared to Liposomal Bupivacaine SAN DIEGO, June 5, 2023 /PRNewswire/ — Cali Biosciences Co., Ltd. (hereinafter referred to as “Cali” or “Cali Biosciences”), a biopharmaceutical company focused … Read more
Het Bedrijf toont zijn onlangs gelanceerde Beacon Select™-technologie voor de ontdekking van antilichamen en de ontwikkeling van cellijnen EMERYVILLE, Californië, 5 juni 2023 /PRNewswire/ — PhenomeX Inc. (Nasdaq: CELL), het bedrijf voor functionele celbiologie, heeft vandaag bekendgemaakt van 6-8 juni 2023 in het Postillion Hotel Amsterdam aan de Antibody Engineering & Therapeutics (AE&T) Europe 2023 … Read more
LOUISVILLE, Colo., June 5, 2023 /PRNewswire/ — Synergy Spine Solutions Ltd, an innovative orthopaedic medical device developer focused on artificial cervical disc replacement, today announced it has completed enrollment in its first-ever IDE clinical trial. The 1-Level Synergy Disc IDE clinical trial (NCT 04469231) enrolled 175 patients in its multi-center, prospective, historically controlled pivotal trial comparing … Read more
NERVIANO, Italy, June 5, 2023 /PRNewswire/ — Nerviano Medical Sciences S.r.l. (NMS), a clinical-stage biotechnology company member of NMS Group S.p.A. (NMS group), the largest cancer research and development company in Italy, announced signing of a license agreement and right of option with Solve Therapeutics, Inc. (SolveTx) to develop and commercialize novel antibody-drug conjugates (ADCs) … Read more
MISSION, Kan., June 5, 2023 /PRNewswire/ — (Family Features) While people may think about heart disease and kidney disease as two different health problems, there are many links between them. Kidney disease affects roughly 1 in 7 (15%) American adults, according to the American Kidney Fund. Photo courtesy of Getty Images Having chronic kidney disease (CKD) … Read more
Early cancer detection is key to improving survival rates and reducing costs of treating cancer. CHICAGO, June 5, 2023 /PRNewswire/ — The American Cancer Society (ACS) and Color Health today announced a partnership that will provide convenient, accessible, and comprehensive cancer prevention and screening solutions for the highest-burden cancers including breast, prostate, lung, cervical, and … Read more
NAPA, Calif., June 5, 2023 /PRNewswire/ — The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, is pleased to announce the appointment of Christa Steele, MBA, to its Board of Governors. Ms. Steele is a financial and governance executive with decades of corporate leadership experience across a wide range of industries. Ms. Steele currently serves on … Read more
The Dutch will be at BIO International Convention in Boston, June 5-8, 2023, to share how companies in the Netherlands are driving innovation that contributes to a healthier world WASHINGTON, June 5, 2023 /PRNewswire/ — The Netherlands is a prime location for biotech companies that bring forth an open-minded, innovative and inclusive approach to novel … Read more
In der ASCO Developmental Therapeutics – Immunotherapy Session präsentiert Dr. Howard Safran ermutigende Daten zur Phase 1/2-Studie von Dragonflys DF1001, einem immunologischen TriNKET®, das auf HER2 bei Patienten mit fortgeschrittenen soliden Tumoren abzielt. WALTHAM, Mass., 5. Juni 2023 /PRNewswire/ — Dragonfly Therapeutics, Inc., ein im klinischen Stadium tätiges Biotechnologieunternehmen, das neuartige Immuntherapien entwickelt, gibt die … Read more